BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9670821)

  • 1. Cyclin D1 gene amplification in esophageal carcinosarcoma shown by differential polymerase chain reaction.
    Suzuki H; Moriya J; Nakahata A; Fujioka Y; Inoue K; Nagashima K
    Hum Pathol; 1998 Jul; 29(7):662-7. PubMed ID: 9670821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 gene amplification and p16 gene deletion in patients with esophageal carcinosarcoma.
    Suzuki H; Fujioka Y; Nagashima K
    Diagn Mol Pathol; 1998 Oct; 7(5):253-9. PubMed ID: 9990483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinosarcoma of the tongue with cyclin D1 gene amplification.
    Suzuki H; Yamashiro K; Yoshida C; Fujioka Y
    Arch Pathol Lab Med; 2001 Mar; 125(3):433-6. PubMed ID: 11231499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
    Amatya VJ; Takeshima Y; Kaneko M; Inai K
    Pathol Int; 2004 Oct; 54(10):803-9. PubMed ID: 15482572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of esophageal sarcomatoid carcinoma with molecular evidence of a monoclonal origin.
    Kashiwabara K; Sano T; Oyama T; Najahima T; Makita F; Hashimoto N; Iwanami K; Kawashima O; Matsumoto T; Matsuzaki Y
    Pathol Res Pract; 2001; 197(1):41-6. PubMed ID: 11209815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.
    Matsumoto T; Fujii H; Arakawa A; Yamasaki S; Sonoue H; Hattori K; Kajiyama Y; Hirose S; Tsurumaru M
    Hum Pathol; 2004 Mar; 35(3):322-7. PubMed ID: 15017588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal carcinosarcoma: a genetic analysis.
    Iwaya T; Maesawa C; Tamura G; Sato N; Ikeda K; Sasaki A; Othuka K; Ishida K; Saito K; Satodate R
    Gastroenterology; 1997 Sep; 113(3):973-7. PubMed ID: 9287991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. True carcinosarcoma of the esophagus.
    Iwaya T; Maesawa C; Uesugi N; Kimura T; Ogasawara S; Ikeda K; Kimura Y; Mitomo S; Ishida K; Sato N; Saito K; Masuda T
    Dis Esophagus; 2006; 19(1):48-52. PubMed ID: 16364045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma.
    Gramlich TL; Fritsch CR; Maurer D; Eberle M; Gansler TS
    Diagn Mol Pathol; 1994 Dec; 3(4):255-9. PubMed ID: 7866635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
    Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
    Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A significant morphological transformation is recognized in human esophageal cancer cells with an amplification/overexpression of the cyclin D1 gene.
    Watanabe M; Kuwano H; Tanaka S; Toh Y; Masuda H; Sugimachi K
    Int J Oncol; 1999 Dec; 15(6):1103-8. PubMed ID: 10568815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
    Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL
    Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change.
    Tsuyama S; Saito T; Akazawa Y; Yanai Y; Yatagai N; Akaike K; Hayashi T; Suehara Y; Takahashi F; Takamochi K; Hashimoto T; Kajiyama Y; Tsurumaru M; Fukunaga T; Yao T
    Virchows Arch; 2019 Oct; 475(4):415-424. PubMed ID: 31444625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of cyclin D1 in aggressive human esophageal cancer.
    Inomata M; Uchino S; Tanimura H; Shiraishi N; Adachi Y; Kitano S
    Oncol Rep; 1998; 5(1):171-6. PubMed ID: 9458316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma.
    Livasy CA; Reading FC; Moore DT; Boggess JF; Lininger RA
    Gynecol Oncol; 2006 Jan; 100(1):101-6. PubMed ID: 16157366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cyclin D1 oncogene and esophageal squamous cell carcinoma.
    Nakagawa H; Zukerberg L; Togawa K; Meltzer SJ; Nishihara T; Rustgi AK
    Cancer; 1995 Aug; 76(4):541-9. PubMed ID: 8625145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Loss of CDKN2 gene and amplification of cyclin D1 gene in human esophageal cancer].
    Zheng J; Hou P; Zhou C
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):408-11. PubMed ID: 9387288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
    Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
    Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 and CDK4 expression in carcinosarcoma of the esophagus: comparison with squamous cell carcinoma and review of the literature.
    Nikitakis NG; Drachenberg CB; Papadimitriou JC
    Exp Mol Pathol; 2002 Dec; 73(3):198-208. PubMed ID: 12565795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.